These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3790418)

  • 1. The effect of ventilatory stimulation with medroxyprogesterone on exercise performance and the sensation of dyspnoea in hypercapnic chronic bronchitis.
    Al-Damluji S
    Br J Dis Chest; 1986 Jul; 80(3):273-9. PubMed ID: 3790418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome.
    Eiser N; Denman WT; West C; Luce P
    Eur Respir J; 1991 Sep; 4(8):926-31. PubMed ID: 1783082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of acetazolamide and medroxyprogesterone as respiratory stimulants in hypercapnic patients with COPD.
    Wagenaar M; Vos P; Heijdra Y; Teppema L; Folgering H
    Chest; 2003 May; 123(5):1450-9. PubMed ID: 12740260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of medroxyprogesterone on ventilatory control and pulmonary gas exchange in chronic obstructive patients.
    Delaunois L; Delwiche JP; Lulling J
    Respiration; 1985; 47(2):107-13. PubMed ID: 3159060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of exercise ventilation by medroxyprogesterone acetate.
    Robertson HT; Schoene RB; Pierson DJ
    Clin Physiol; 1982 Aug; 2(4):269-76. PubMed ID: 6813017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Almitrine improves oxygenation when both awake and asleep in patients with hypoxia and carbon dioxide retention caused by chronic bronchitis and emphysema.
    Connaughton JJ; Douglas NJ; Morgan AD; Shapiro CM; Critchley JA; Pauly N; Flenley DC
    Am Rev Respir Dis; 1985 Aug; 132(2):206-10. PubMed ID: 4026044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients.
    Wagenaar M; Vos PJ; Heijdra YF; Teppema LJ; Folgering HT
    Eur Respir J; 2002 Nov; 20(5):1130-7. PubMed ID: 12449165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of almitrine or oxygen breathing on pulmonary arterial pressure and right ventricular ejection fraction in hypoxic chronic bronchitis and emphysema.
    MacNee W; Connaughton JJ; Rhind GB; Hayhurst MD; Douglas NJ; Muir AL; Flenley DC
    Am Rev Respir Dis; 1986 Sep; 134(3):559-65. PubMed ID: 3752712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis.
    Leitch AG; Hopkin JM; Ellis DA; Merchant S; McHardy GJ
    Thorax; 1978 Dec; 33(6):711-3. PubMed ID: 154748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of naftidrofuryl on breathlessness and exercise tolerance in chronic bronchitis.
    Williams AJ; Osman J; Skinner C
    Thorax; 1982 Aug; 37(8):617-9. PubMed ID: 7179191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral progesterone treatment in chronic obstructive lung disease: failure of voluntary hyperventilation to predict response.
    Morrison DA; Goldman AL
    Thorax; 1986 Aug; 41(8):616-9. PubMed ID: 2947345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of CO2 retention during sleep in patients with chronic obstructive pulmonary diseases.
    Skatrud JB; Dempsey JA; Iber C; Berssenbrugge A
    Am Rev Respir Dis; 1981 Sep; 124(3):260-8. PubMed ID: 7025715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide.
    Spence DP; Hay JG; Carter J; Pearson MG; Calverley PM
    Thorax; 1993 Nov; 48(11):1145-50. PubMed ID: 8296259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma theophylline concentrations, six minute walking distances, and breathlessness in patients with chronic airflow obstruction.
    Evans WV
    Br Med J (Clin Res Ed); 1984 Dec; 289(6459):1649-51. PubMed ID: 6439360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indices of pulmonary ventilatory function, FEV-1, FEF-25-75% and FEF-75-85% in relation to exercise dyspnea and symptoms of chronic bronchitis].
    Jedrychowski W
    Pneumonol Pol; 1979 Jan; 47(1):25-31. PubMed ID: 419008
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemodynamic effect of deslanoside at rest and during exercise in patients with chronic bronchitis.
    Jezek V; Schrijen F
    Br Heart J; 1973 Jan; 35(1):2-8. PubMed ID: 4685903
    [No Abstract]   [Full Text] [Related]  

  • 17. Exertional dyspnoea in patients with airway obstruction, with and without CO2 retention.
    Cloosterman SG; Hofland ID; van Schayck CP; Folgering HT
    Thorax; 1998 Sep; 53(9):768-74. PubMed ID: 10319059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral salbutamol and slow-release aminophylline on exercise tolerance in chronic bronchitis.
    Leitch AG; Morgan A; Ellis DA; Bell G; Haslett C; McHardy GJ
    Thorax; 1981 Oct; 36(10):787-9. PubMed ID: 7036401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD.
    Díaz O; Bégin P; Andresen M; Prieto ME; Castillo C; Jorquera J; Lisboa C
    Eur Respir J; 2005 Dec; 26(6):1016-23. PubMed ID: 16319330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon monoxide and exercise tolerance in chronic bronchitis and emphysema.
    Calverley PM; Leggett RJ; Flenley DC
    Br Med J (Clin Res Ed); 1981 Oct; 283(6296):878-80. PubMed ID: 6793157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.